Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR. Eric Davis, Louis M. Staudt, Hong Zhao et al.|Nature|2010Cited by 1.6k
Oncogenically active MYD88 mutations in human lymphomaVu N. Ngo, Louis M. Staudt, Ryan M. Young et al.|Nature|2010Cited by 1.5k
Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative ManagementLeila T. Tchelebi, Michael D. Chuong, Paul B. Romesser et al.|Cancer Control|2020Cited by 12
Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Cancer Research|2024Cited by 4